These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2007-005034-36||A non comparative, multicentre, repeat dose safety in use study of Neukine® (Filgrastim) in patients receiving chemotherapy known to induce neutropenia||2010-05-12||due-trials|
|Reported results||2011-002678-21||A PHASE III, RANDOMIZED, ACTIVE CONTROLLED, ASSESSORBLINDED||2014-05-30||due-trials|
|Listed as ongoing, but also has a completion date||2011-005057-31||A phase III, randomized, assessor-blinded, active-controlled, multicenter study of the efficacy and safety of APO-EPO as compared to Procrit® when given subcutaneously to patients with anemia of chron...||2017-09-18||bad-data|
|Not reported Terminated||2011-005058-70||A phase III, randomized, open-label, active-controlled, multicenter, correction phase study of the efficacy, safety, pharmacokinetics, and pharmacodynamics of APO-EPO (epoetin alfa) as compared to Epo...||2013-03-14||due-trials|